Biotech News

When picking up a delicate egg, they can't instinctively modulate how hard they're gripping it.

Teva Pharmaceutical Industries Ltd said it settled a patent litigation with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster pain medication, Celebrex, in December.

U.S. regulators have again approved a Merck & Co. tablet for gradually reducing seasonal allergies, this time for ragweed pollen.

Drugmaker GlaxoSmithKline - hit by bribery claims in five countries - is to employ hundreds more doctors as members of staff as it seeks to build a new sales model designed to eliminate sharp marketing practices.

An Albany-based pharmaceutical company that's part of a $250 million economic development project in Buffalo is shutting down its Syracuse-area research center, eliminating 45 jobs.

GlaxoSmithKline, Britain's biggest drugmaker, said on Wednesday it was investigating allegations of bribery involving some of its staff in Jordan and Lebanon, following earlier claims of corruption in China, Poland and Iraq.

Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC.

In this Friday, March 1, 2013 file photo, Chan Lai Ly, right, has his mouth examined by Honghue Duong, a physician's assistant, as part of a regular check-up related to his diabetes at International Community Health Services in Seattle.

The Vermont Senate passed a bill on Wednesday that would make the state the first in the United States to enact mandatory labeling of foods made with genetically modified crops.

Several smartphone apps are available to help patients take their medications as prescribed.

The company said Wednesday that it started looking into the conduct of "a small number of individuals" in December.

Dr. Reddy's Laboratories announced today that it has launched Eszopiclone Tablets 1 mg, 2 mg and 3 mg, a therapeutic equivalent generic version of LUNESTAA tablets C-IV in the US market on April 15, 2014, following the approval by the United States Food & Drug Administration .

Stock index futures edged up on Tuesday after earnings from Coca Cola and Johnson & Johnson and ahead of economic data including inflation and manufacturing.

World markets turned lower on Tuesday amid concerns about instability in Ukraine, the value of technology stocks and an economic slowdown in China.

1 spot in the Tampa Bay Times' Top Workplaces list for 2014. It is the third time in five years for ASI to earn the a... )--The recently discovered fracture at the Wanapum Dam's spillway structure does not currently impact bond ratings for the project's owner, the Public Utility District No.

Major U.S. stock indexes are turning higher in the late afternoon as the market shuffles between gains and losses.

Scientists using a remote-controlled robot submersible have discovered a new species of poisonous sponge in deep waters off San Diego.

Beazer Homes, Ryland Group and other homebuilder stocks fell after a survey showed that the industry's confidence in the housing market remains low.

Once you're logged in, at the top of each article, video or slideshow you will see a list of your Facebook friends who recently visited Choose to share stories you'e read with your friends or turn sharing OFF to keep your reading experience anonymous .

Johnson & Johnson says its first-quarter profit rose 8 percent, because of restrained costs and a big jump in prescription drug sales.